Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Dec 29:12:183.
doi: 10.1186/1471-230X-12-183.

Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option

Kathy L Flitcroft  1 , Les M Irwig, Stacy M Carter, Glenn P Salkeld, James A Gillespie
Affiliations
Review

Colorectal cancer screening: why immunochemical fecal occult blood tests may be the best option

Kathy L Flitcroft et al. BMC Gastroenterol. .

Abstract

Background: There are many test options available for colorectal cancer screening. The choice of test relates to the objectives of those offering or considering screening.

Discussion: While all screening programs aim to detect disease early in order to improve the length and/or quality of life for the individual, some organizations and individuals prefer screening tests that offer the opportunity for cancer prevention. Others favor maximizing participation or the opportunity for shared decision-making, including discussion of information on test quality and availability. We propose three additional objectives for screening: minimizing harms, optimizing economic efficiency and maximizing equity of access to screening.

Summary: Applying these objectives to colorectal cancer screening, we advocate the use of immunochemical FOBTs as the preferred screening strategy, as it satisfies all three of these important objectives.

PubMed Disclaimer

References

    1. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the American college of radiology. Gastroenterology. 2008;134:1570–1595. doi: 10.1053/j.gastro.2008.02.002. - DOI - PubMed
    1. S. Preventive Services Task Force. Screening for colorectal cancer: U.S preventive services task force recommendation statement. Ann Intern Med. 2008;149:627–637. - PubMed
    1. Howard K, Salkeld G, Irwig L, Adelstein B-A. High participation rates are not necessary for cost-effective colorectal cancer screening. J Med Screen. 2005;12(2):96–102. doi: 10.1258/0969141053908276. - DOI - PubMed
    1. Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM. American college of gastroenterology guidelines for colorectal cancer screening. Am J Gastroenterol. 2009;104:739–750. doi: 10.1038/ajg.2009.104. - DOI - PubMed
    1. Entwistle VA, Carter SM, Trevena LJ, Flitcroft KL, Irwig LM, McCaffery K, Salkeld G. Communicating about screening: a proposed new direction. BMJ. 2008;337:789–791. doi: 10.1136/bmj.a789. - DOI - PubMed

Publication types